ВЛИЯНИЕ САКУБИТРИЛ/ВАЛСАРТАНА НА НАТРИЙУРЕЗ, ДИУРЕЗ И УРОВЕНЬ АРТЕРИАЛЬНОГО ДАВЛЕНИЯ У ПАЦИЕНТОВ С АРТЕРИАЛЬНОЙ ГИПЕРТОНИЕЙ Article Кобалава Ж.Д., Виллевальде С.В., Мерай И.А., Лукина О.И. Rational Pharmacotherapy in Cardiology. Stolichnaya Izdatelskaya Kompaniya. Vol. 13. 2017. P. 370-377
(-75)G ALLELE OF APOA1 GENE IS ASSOCIATED WITH NON-ATTAINMENT OF TARGET LIPID LEVELS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS Article Vorobyeva M., Gigani O., Azova M., Villevalde S., Kobalava Z. European Journal of Heart Failure. Elsevier Science Publishing Company, Inc.. Vol. 19. 2017. P. 159-159
ONE YEAR SACUBITRIL/VALSARTAN THERAPY IS ASSOCIATED WITH DECREASE OF ARTERIAL STIFFNESS IN PATIENTS WITH STABLE HEART FAILURE WITH REDUCED EJECTION FRACTION Article Kobalava Z., Villevalde S., Lukina O., Babaeva L., Meray I. Journal of Hypertension. Vol. 35. 2017.
HIGH PREVALENCE OF RENAL DYSFUNCTION AND ALBUMINURIA IN PATIENTS WITH ARTERIAL HYPERTENSION AND DIABETES MELLITUS IN HOSPITAL CLINICAL PRACTICE Article Villevalde S., Kobalava Z., Kulakov V., Manukhina N. Journal of Hypertension. Vol. 35. 2017.
ANTIHYPERTENSIVE EFFICACY OF FIXED COMBINATION AZILSARTAN MEDOXOMIL/CHLORTHALIDONE IN PATIENTS WITH UNCONTROLLED ARTERIAL HYPERTENSION Article Kobalava Z.D., Villevalde S.V., Kulakov V.V. Kardiologiia. KlinMed Consulting. Vol. 57. 2017. P. 12-18
VALVE CALCIFICATION IS ASSOCIATED WITH PARAMETERS OF CENTRAL PULSE WAVE IN PATIENTS WITH END-STAGE RENAL DISEASE ON HEMODIALYSIS Article Manukhina N., Trukhanova M., Villevalde S., Kobalava Z. European Journal of Heart Failure. Elsevier Science Publishing Company, Inc.. Vol. 19. 2017. P. 566-566
BASELINE KIDNEY FUNCTION AND BLOOD PRESSURE LEVEL ARE MAIN PREDICTORS OF ACUTE KIDNEY INJURY IN PATIENTS ADMITTED WITH CARDIAC DISEASES Article Efremovtseva M., Villevalde S., Kobalava Z., Avdishina S. Journal of Hypertension. Vol. 35. 2017.
АЛИРОКУМАБ: НОВЫЕ ПЕРСПЕКТИВЫ ЛИПИДСНИЖАЮЩЕЙ ТЕРАПИИ Article Кобалава Ж.Д., Виллевальде С.В., Воробьева М.А. Terapevticheskii Arkhiv. Vol. 89. 2017. P. 114-121
TREATMENT WITH AZILSARTAN MEDOXOMIL IMPROVED DIPPING STATUS IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS Article Kulakov V., Starostina E., Troitskaya E., Villevalde S., Kobalava Z. Journal of Hypertension. Vol. 35. 2017.
CARDIORENOHEPATIC SYNDROME REFLECTS SEVERITY OF DECOMPENSATED HEART FAILURE AND IS RELATED WITH WORSE PROGNOSIS Article Kobalava Z., Soloveva A., Villevalde S. European Heart Journal. Vol. 38. 2017. P. 862-862
LONG-TERM SACUBITRIL/VALSARTAN THERAPY IMPROVED CENTRAL PULSE WAVE PARAMETERS IN PATIENTS WITH STABLE HEART FAILURE WITH REDUCED EJECTION FRACTION Article Kobalava Z., Villevalde S., Lukina O., Babaeva L., Meray I. European Journal of Heart Failure. Elsevier Science Publishing Company, Inc.. Vol. 19. 2017. P. 208-209
GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS Article Vorobyeva M.A., Azova M.M., Gigani O.O., Garmash I.V., Villevalde S.V., Kobalava Z.D. Rational Pharmacotherapy in Cardiology. Stolichnaya Izdatelskaya Kompaniya. Vol. 13. 2017. P. 525-531
PREVALENCE AND PROGNOSTIC SIGNIFICANCE OF CARDIORENAL ANEMIC SYNDROME IN PATIENTS WITH OF ACUTE CARDIOVASCULAR DISEASES Article Efremovtseva M., Avdoshina S., Kobalava Z., Villevalde S., Kurmanov M. NEPHROLOGY DIALYSIS TRANSPLANTATION. Oxford University Press. Vol. 32. 2017. P. 583-583
LEFT VENTRICULAR-ARTERIAL UNCOUPLING IS ASSOCIATED WITH EARLY CARDIAC REMODELING IN PATIENTS WITH MYOCARDIAL INFARCTION TREATED WITH PERCUTANEOUS CORONARY INTERVENTION Article Zharikova E., Villevalde S., Kobalava Z.H. European Journal of Heart Failure. Elsevier Science Publishing Company, Inc.. Vol. 19. 2017. P. 320-321
EFFICIENT IMPLEMENTATION OF ALGORITHM PREVENTING IN CLINICAL PRACTICE OF CONTRAST-INDUCED ACUTE KIDNEY INJURY IN PATIENT WITH DELAYED PERCUTANEOUS CORONARY INTERVENTIONS Article Kobalava Z., Gaskina A., Villevalde S. European Heart Journal. Vol. 38. 2017. P. 513-513